Hyogo, Japan

Tomohiro Sakurai

This inventor holds 1 USPTO granted patent. Top assignee: Sysmex Corporation. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohiro Sakurai. Retrieved from https://idiyas.com/inventor/tomohiro-sakurai-j6txht9i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomohiro Sakurai: Innovator in Erythrocyte Morphology Detection

Introduction

Tomohiro Sakurai is a notable inventor based in Hyogo-ken, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of abnormalities in erythrocyte morphology. His innovative approach has the potential to enhance the accuracy of blood analysis.

Latest Patents

Sakurai holds a patent for a method titled "Method for detecting abnormal morphology of erythrocytes." This method provides a systematic approach to identifying abnormalities in the shape and structure of red blood cells, which is crucial for diagnosing various medical conditions.

Career Highlights

Tomohiro Sakurai is associated with Sysmex Corporation, a leading company in the field of medical diagnostics and laboratory testing. His work at Sysmex has allowed him to focus on developing advanced technologies that improve patient care and diagnostic accuracy.

Collaborations

Sakurai has collaborated with notable colleagues, including Yuji Itose and Kayo Hatanaka. Their combined expertise has contributed to the development of innovative solutions in the medical diagnostics sector.

Conclusion

Tomohiro Sakurai's contributions to the field of erythrocyte morphology detection exemplify the impact of innovation in medical technology. His work continues to influence advancements in diagnostic methods, ultimately benefiting patient health and care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…